Rheumatoid Arthritis: Current and Emerging Paradigms of Diagnosis and Treatment DOI Creative Commons

Rajni Kaur,

Hitesh Kumar Dewangan

International Journal of Life Science and Pharma Research, Journal Year: 2023, Volume and Issue: unknown

Published: Nov. 1, 2023

Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by inflammation and damage to joints andtissues. While previous reviews exist, there still needs be more in understanding risk factors, diagnostic methods, treatmentoptions. This review aims fill these gaps providing comprehensive overview of recent advancements the field. To addressthe limitations reviews, this article incorporates updated information on including influence ofenvironmental factors industrialized nations. It highlights significance early RA diagnosis emphasizes utility ofdynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for effective disease management. Moreover, reviewintroduces innovative nanotechnology-based treatment approaches RA. explores potential gold nanoparticles, carbonnanotubes, polymer-based nanomedicine, nanoliposomes targeting specific inflammatory sites improving treatmenteffectiveness. present an up-to-date analysis RA, bridging literature byintroducing novel techniques exploring emerging modalities. By synthesizing current knowledge andoutlining future research prospects, advance rheumatoid arthritis.Additionally, discusses systemic complications associated with such as vasculitis Feltysyndrome. also sheds light long-term consequences untreated need joint replacementsurgery (arthroplasty) splenectomy. aspects, enhance theholistic guide toward improved management patient outcomes.

Language: Английский

Red Blood Cell Distribution Width: A Potential Inexpensive Marker for Disease Activity in Patients with Rheumatic Diseases; Scoping Review DOI Creative Commons
Mushabab Alghamdi

Open Access Rheumatology Research and Reviews, Journal Year: 2023, Volume and Issue: Volume 15, P. 173 - 180

Published: Sept. 1, 2023

Background: Rheumatic diseases encompass a diverse group of autoimmune disorders that affect the joints and connective tissues. The red blood cell distribution width (RDW) has been widely investigated as an inflammatory marker. This scoping review aimed to explore potential utility RDW inexpensive marker for disease activity in patients with rheumatic diseases. By summarizing available evidence, we determine whether can serve reliable accessible indicator these patients. Methods: A comprehensive search was systematically performed across electronic databases, encompassing PubMed, Embase, Web Science. Studies have explored relationship between Data extraction focused on study characteristics, methodologies, findings related Results: After removing duplicates, initial yielded 25 relevant studies. These studies encompassed variety diseases, rheumatoid arthritis being most frequently studied condition. association assessed by using various indices clinical parameters. While some reported significant correlation elevated activity, others inconclusive results. Conclusion: From this review, concluded is evaluation promising readily marker; however, its assessing conditions warrants more rigorous investigation through well-designed prospective Keywords: width, RDW, marker,

Language: Английский

Citations

7

Zein-Derived Peptides from Corn Promote the Proliferation of C2C12 Myoblasts via Crosstalk of mTORC1 and mTORC2 Signaling Pathways DOI Creative Commons

Mohammad Sadiq Amin,

Binbin Yu,

Dongjing Wu

et al.

Foods, Journal Year: 2024, Volume and Issue: 13(6), P. 919 - 919

Published: March 18, 2024

Dietary protein supplementation has emerged as a promising strategy in combating sarcopenia. Furthermore, searching for alternatives of animal proteins been hot topic. The present study aimed to investigate the effects zein peptides on C2C12 myoblasts and explore their potential molecular mechanisms. proliferative, cell cycle, anti-apoptotic activities were evaluated. Peptidomics analysis transcriptome sequencing employed structure-activity relationship underlying results indicated that (0.05–0.2 mg/mL) exerted significant proliferation-promoting impact cells, via increasing viability by 33.37 42.39%. significantly increased S phase proportion decreased apoptosis rate from 34.08% (model group) 28.96% cells. In addition, exhibited pronounced effect Zein are abundant branch-chain amino acids, especially leucine. Transcriptomics revealed can promote proliferation, accelerate improve synthesis muscle cells through mTORC1 mTORC2 signaling pathways.

Language: Английский

Citations

2

Investigating the therapeutic potential of sinomenine in rheumatoid arthritis: anti-inflammatory, antioxidant, and immunomodulatory mechanisms DOI
Juan Li, Junjie Cao,

Qingping Chen

et al.

Naunyn-Schmiedeberg s Archives of Pharmacology, Journal Year: 2023, Volume and Issue: 397(6), P. 3945 - 3958

Published: Nov. 22, 2023

Language: Английский

Citations

4

Bio-intelligent plasma-engineered diferuloylmethane/fucoidan/neutrophil lysate/iron oxide nanoclusters for phototherapeutic and magnetotherapeutic with in situ magnetic gelation mitigating inflammatory diseases DOI
Andrew E.‐Y. Chuang,

Yung-Wei Lin,

Pei‐Ru Jheng

et al.

Colloids and Surfaces B Biointerfaces, Journal Year: 2024, Volume and Issue: 243, P. 114054 - 114054

Published: July 4, 2024

Language: Английский

Citations

1

Local and Systemic Peptide Therapies for Soft Tissue Regeneration: A Narrative Review DOI Creative Commons

Caroline J. Cushman,

Andrew Ibrahim,

Alexander D Smith

et al.

The Yale Journal of Biology and Medicine, Journal Year: 2024, Volume and Issue: 97(3), P. 399 - 413

Published: Sept. 30, 2024

: The musculoskeletal system, due to inherent structure and function, lends itself contributing toward joint pain, whether from inflammatory disorders such as rheumatoid arthritis, degenerative diseases osteoarthritis, or trauma causing soft tissue injury. Administration of peptides for treatment pain inflammation is an emerging line therapy that seeks offer therapeutic benefits while remaining safe relatively non-invasive.

Language: Английский

Citations

1

Deep-Insights: Nanoengineered Gel-Based Localized Drug Delivery for Arthritis Management DOI Creative Commons

Anitha Sriram,

Harshada Ithape,

Pankaj Kumar Singh

et al.

Asian Journal of Pharmaceutical Sciences, Journal Year: 2024, Volume and Issue: 20(1), P. 101012 - 101012

Published: Dec. 20, 2024

Arthritis is an inflammatory joint disorder that progressively impairs function and diminishes quality of life. Conventional therapies often prove ineffective, as oral administration lacks specificity, resulting in off-target side effects like hepatotoxicity GIT-related issues. Intravenous causes systemic effects. The characteristic joint-localized symptoms such pain, stiffness, inflammation make the localized drug delivery suitable for managing arthritis. Topical/transdermal/intra-articular routes have become viable options treating However, challenges with those include skin barrier cartilage impermeability. Additionally, conventional intra-articular also leads to rapid clearance drugs from synovial tissue. To circumvent these limitations, researchers developed nanocarriers enhance permeability through cartilage, influencing action. Gel-based nanoengineered therapy employs a gel matrix incorporate drug-encapsulated nanocarriers. This approach combines benefits gels therapeutic improve patient compliance. review emphasizes deep insights into using diverse gel-based novel nanocarriers, exploring their various applications embedded hyaluronic acid (biopolymer)-based gels, carbopol-based others. Furthermore, this discusses influence nanocarrier pharmacokinetics on localization manipulation macrophages mediated by ELVIS (extravasation leaky vasculature cell-mediated sequestration) effect associated arthritis advantageous delivery. Simply put, refers extravasation vasculatures, which finally results accumulation cavity.

Language: Английский

Citations

1

A supramolecular assembly strategy for the treatment of rheumatoid arthritis with ultrasound-augmented inflammatory microenvironment reprograming DOI

Fuhong Yang,

Jingqi Lv,

Yanli Huang

et al.

Biomaterials, Journal Year: 2024, Volume and Issue: 316, P. 123006 - 123006

Published: Dec. 11, 2024

Language: Английский

Citations

0

Rheumatoid Arthritis: Current and Emerging Paradigms of Diagnosis and Treatment DOI Creative Commons

Rajni Kaur,

Hitesh Kumar Dewangan

International Journal of Life Science and Pharma Research, Journal Year: 2023, Volume and Issue: unknown

Published: Nov. 1, 2023

Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by inflammation and damage to joints andtissues. While previous reviews exist, there still needs be more in understanding risk factors, diagnostic methods, treatmentoptions. This review aims fill these gaps providing comprehensive overview of recent advancements the field. To addressthe limitations reviews, this article incorporates updated information on including influence ofenvironmental factors industrialized nations. It highlights significance early RA diagnosis emphasizes utility ofdynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) for effective disease management. Moreover, reviewintroduces innovative nanotechnology-based treatment approaches RA. explores potential gold nanoparticles, carbonnanotubes, polymer-based nanomedicine, nanoliposomes targeting specific inflammatory sites improving treatmenteffectiveness. present an up-to-date analysis RA, bridging literature byintroducing novel techniques exploring emerging modalities. By synthesizing current knowledge andoutlining future research prospects, advance rheumatoid arthritis.Additionally, discusses systemic complications associated with such as vasculitis Feltysyndrome. also sheds light long-term consequences untreated need joint replacementsurgery (arthroplasty) splenectomy. aspects, enhance theholistic guide toward improved management patient outcomes.

Language: Английский

Citations

0